Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:49 PM
Ignite Modification Date:
2025-12-24 @ 2:49 PM
NCT ID:
NCT04289259
Eligibility Criteria:
Inclusion Criteria:
* Patient with any NSCLC, stage III and IV with a molecular analysis on the French platform. There will be no exclusion criteria on the presence of an oncogenic mutation as EGFR, KRAS, ALK.
* Patient age will be ≥ 18 years old and \< 85 years old
* The pre-analytical features of the patient's sample are compatible with the CGP / WES analysis.
* Patient has signed the ICF.
* The FFPE material from the patient's sample needs to be available to be analyzed on site and sent for central analyses. If FFPE sample is not available within 1 month, on-site analysis can begin on extracted DNA previously screened in small panel NGS.
* The neoplastic cells in the patient's sample should be superior to 30%.
Exclusion Criteria:
* The TMB in patient's NSCLC is already known or estimated in the case of a clinical trial.
* Patient with relapsing NSCLC if the initial cancer has received a neoadjuvant / adjuvant treatment.
* Patient under legal protection
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT04289259
Study Brief:
Protocol Section:
NCT04289259